Navigation Links
Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
Date:5/28/2008

ored by a major pharmaceuticals company.

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; Prodrax(R), a non-toxic prodrug which is activated in the hypoxic zones of solid tumors to kill cancer cells; and Alchemix, a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com .

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our ability to close the financing transaction, early results from our clinical trial, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited to Access' need to obtain additional financing in order to continue the clinical trial a
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
2. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
3. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
4. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
5. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
6. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
7. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
10. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
11. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  For many businesses and industries just one ... case, having the right management software can be an ... than software solutions company TraxStar Technologies , creators ... company announced the release of the newest version of ... "QATrax is ...
(Date:4/1/2015)...  The U.S. Food and Drug Administration has ... wireless maternal/fetal monitoring system to be marketed for ... self-administer non-stress tests (NST). Sense4Baby already ... accompanied by medical professionals. Sense4Baby also received the ... for self-administration, including the home. This ...
(Date:4/1/2015)... , April 1, 2015  RegeneRx Biopharmaceuticals, Inc. ... that a new medical paper has been published ... (TB4) in patients with severe dry eye.  The ... and the physicians stated that statistically significant differences ... eye were seen at various time points throughout ...
Breaking Medicine Technology:TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
... Feb. 9, 2011 Rcadia Medical Imaging announced today ... an enhanced version of its COR Analyzer® System to ... arteries in patients with suspected coronary artery disease (CAD). ... System, a unique clinical decision support tool that automatically ...
... N.Y., Feb. 9, 2011 Misonix, Inc. (Nasdaq: ... that designs, manufactures, and markets innovative, therapeutic, ultrasonic ... laparoscopic surgery, and other surgical and medical applications, ... quarter and six months ending December 31, 2010. ...
Cached Medicine Technology:Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels 2Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 2Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 3Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 4Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 5Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results 6
(Date:4/1/2015)... IQ Formulations , one of the most highly ... the U.S., today is commending GNC for taking steps to ... its herbal supplements.* GNC vowed that its new processes will ... of labeling on its products. , In response to ... CEO Jay Cohen said: , “In a lightly-regulated industry ...
(Date:4/1/2015)... Boys & Girls Clubs of America ... water safety education, today announced at a press conference ... Children’s Cabinet, that the organizations will work together for ... and swim instruction to thousands of children across the ... partnership provides swimming-safety instruction to more than 2,500 Club ...
(Date:4/1/2015)... Albany, New York (PRWEB) April 01, 2015 ... Nursing will host its annual Educational Institute in ... nursing empowerment, innovations, and initiatives in nursing and feature an ... FAAN, E. Jean M. Hill Professor, University of Kansas School ... , The event is being sponsored by the Excelsior ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 Nike ... camps for boys and girls ages 10-17, providing campers ... elite athletes. Players will experience all 4 Grand Slam ... tennis centre, home of Great Britain’s Davis Cup team ... the edge of Richmond Park, the National Tennis Centre ...
(Date:4/1/2015)... Patients with inoperable mesothelioma may soon ... to the FDA’s approval of CRS-207’s orphan drug application ... on the Surviving Mesothelioma website. , CRS-207 ... of the bacteria that causes the food-borne illness Listeriosis. ... funding and other incentives to support continued testing and ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Boys & Girls Clubs of America and The ZAC Foundation Announce Third Year of National Partnership to Bring Water Safety Education to 20 Cities Across the Country 2Health News:Boys & Girls Clubs of America and The ZAC Foundation Announce Third Year of National Partnership to Bring Water Safety Education to 20 Cities Across the Country 3Health News:Boys & Girls Clubs of America and The ZAC Foundation Announce Third Year of National Partnership to Bring Water Safety Education to 20 Cities Across the Country 4Health News:Excelsior College School of Nursing Educational Institute to Influence Nursing Empowerment 2Health News:Excelsior College School of Nursing Educational Institute to Influence Nursing Empowerment 3Health News:US Sports Camps and Nike Tennis Camps to Launch in London, England this Summer 2Health News:Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma 2
... that hepatitis C virus infection is a bad ... in renal transplant recipients//. ,Hepatitis C virus (HCV) ... recipients; the prevalence depends on the geographic area. ... renal transplant recipients. ,Researchers from the Armed ...
... Health Minister Anbumani Ramadoss has said that the government is ... and plans to take several steps to check female foeticide, ... ,Dr Ramadoss said that there were plans to set up ... unfortunate practice that prevails on a large scale in the ...
... is to be started by British Heart Foundation to encourage children’s ... the food which will help them to educate about healthier foods//. ... content of the foods they eat. ,More than 10% ... and 37% of children’s were not aware that cheese was made ...
... Institute of Medical Research (QIMR) have found that regular ... which are precursors to skin cancer//. The study was ... Dermatology. ,Aspirin is a cyto-oxygenase (COX) enzyme ... its expression. The COX gene is gene coded which ...
... Clinical Global Health Education was started by Bob Bollinger ... care to patients would improve only if health care ... was to provide training by John Hopkins through Global ... providers. Bollinger said, “Don’t wait for poorly funded medical ...
... Recent research demonstrates that erythrocyte sedimentation rate (ESR) ... haemoglobin concentration significantly influence ESR//. ,The erythrocyte ... the acute phase response. It is helpful in ... to treatment. It is influenced by anaemia, which ...
Cached Medicine News:Health News:John Hopkins CGHH program provides Global Health education 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: